| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.08 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |